Variant report
Variant | nsv1011845 |
---|---|
Chromosome Location | chr4:125273444-125325694 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANKRD50-2 | chr4:125298864-125299036 | XLOC_004063 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000151458 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182494959 | chr4:125281229-125281230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148574925 | chr4:125281252-125281253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531940515 | chr4:125281262-125281263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs17008080 | chr4:125281321-125281322 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs144522332 | chr4:125281382-125281383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563797403 | chr4:125281406-125281407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370697385 | chr4:125281414-125281415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs512626 | chr4:125281441-125281442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549564798 | chr4:125281492-125281493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567859240 | chr4:125281512-125281513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62322024 | chr4:125281556-125281557 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs6829829 | chr4:125281567-125281568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs62322025 | chr4:125281570-125281571 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs565362203 | chr4:125281572-125281573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs586772 | chr4:125281591-125281592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557396372 | chr4:125281594-125281595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs13119212 | chr4:125281631-125281632 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs114850011 | chr4:125281666-125281667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555585181 | chr4:125281671-125281672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573845633 | chr4:125281742-125281743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375565671 | chr4:125281754-125281755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541351626 | chr4:125281774-125281775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553381309 | chr4:125281814-125281815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs578052687 | chr4:125281844-125281845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10709098 | chr4:125281887-125281888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs397692212 | chr4:125281897-125281898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545437590 | chr4:125281905-125281906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs62319360 | chr4:125281927-125281928 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs112484970 | chr4:125281930-125281931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs77114811 | chr4:125281963-125281964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs189203201 | chr4:125282001-125282002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs146598256 | chr4:125282037-125282038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368596582 | chr4:125282050-125282051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192371545 | chr4:125282093-125282094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546858096 | chr4:125282107-125282108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571622583 | chr4:125282113-125282114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532726456 | chr4:125282124-125282125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs72676682 | chr4:125282138-125282139 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs370309310 | chr4:125282139-125282140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569646896 | chr4:125282188-125282189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537191424 | chr4:125282200-125282201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548890251 | chr4:125282209-125282210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184413248 | chr4:125282215-125282216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534834199 | chr4:125282223-125282224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553273305 | chr4:125282289-125282290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs372718345 | chr4:125282290-125282291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs578007413 | chr4:125282310-125282311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538988702 | chr4:125282313-125282314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557364099 | chr4:125282366-125282367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575631396 | chr4:125282390-125282391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Developmental delay | 21147756 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:125281200-125284000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr4:125282400-125282600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr4:125294600-125294800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr4:125294800-125295600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr4:125295600-125296000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr4:125296000-125296200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr4:125304000-125305000 | Enhancers | Fetal Lung | lung |
8 | chr4:125307000-125308200 | Enhancers | Colon Smooth Muscle | Colon |
9 | chr4:125307200-125307600 | Enhancers | Rectal Smooth Muscle | rectum |
10 | chr4:125307400-125308200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr4:125310400-125312200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr4:125310400-125312400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr4:125310400-125312400 | Enhancers | Muscle Satellite Cultured Cells | -- |
14 | chr4:125310800-125311800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr4:125311000-125311800 | Enhancers | NHEK | skin |
16 | chr4:125311600-125312200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr4:125311600-125312400 | Enhancers | Fetal Lung | lung |
18 | chr4:125320400-125321000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr4:125320400-125321200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
20 | chr4:125320400-125321400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr4:125320800-125321200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
22 | chr4:125322600-125323600 | Enhancers | HUVEC | blood vessel |